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FOREWORD 
 
A ROT IN HEAVEN 
A POWERFUL INVESTIGATIVE PARTNERSHIP, 
THE OPIOID CRISIS, PILL PROFITS, AND A 
PULITZER PRIZE 
 
Becky L. Jacobs* 
 
“Almost Heaven, West Virginia” 
Bill Danoff, Taffy Nivert, and John Denver1 
“All the host of heaven shall rot away, and the skies roll up like a 
scroll.” 
Isaiah 34:42 
_________________________________ 
In the spring of 2018, when the Tennessee Journal 
of Law and Policy hosted the “Healing Appalachia: The 
Role of Professionals in Solving the Opioid Crisis” 
symposium, there were more than 400 lawsuits pending 
against corporations that manufacture, distribute, and 
retail opioids in just one consolidated case in the federal 
                                               
* Waller Lansden Distinguished Professor of Law, The 
University of Tennessee College of Law. Email: 
jacobs@utk.edu. 
1 Bill Danoff, Taffy Nivert & John Denver, Take Me Home, 
Country Roads (April 12, 1971).  
2 Isaiah 34:4 (English Standard Version). 
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district court for the Northern District of Ohio.3 This 
single, consolidated case initially involved only claims 
brought by governmental entities, but the Judicial Panel 
on Multidistrict Litigation consolidating the cases 
acknowledged that the action potentially could include 
claims brought by individuals, consumers, hospitals, and 
third party payors, as well as additional categories of 
defendants.4  
It is not hyperbole to say that we can thank Eric 
Eyre of the Charleston Gazette-Mail, of Charleston, West 
Virginia, for these lawsuits and for the momentum that 
we now are experiencing in support of a response to the 
national opioid crisis. The government, the legal 
community, and many media outlets seemingly were 
willing to ignore the opiate plague that was infecting our 
communities, but Eric’s Pulitzer Prize-winning series of 
articles5 made it impossible for anyone to profess 
ignorance any longer.  
As lawyers, we also should take pride in the role 
that our colleagues from WVU College of Law, Pat 
McGinley and Suzanne Weise, played in supporting 
Eric’s efforts to uncover the shocking data that appeared 
                                               
3 In re Nat’l Prescription Opiate Litig., MDL No. 1:17-MD-2804 
(N.D. Ohio 2017) [hereinafter “MDL Litigation”]; see also Jan 
Hoffman, Can This Judge Solve the Opioid Crisis?, N.Y. TIMES 
(Mar. 7, 2018), https://www.nytimes.com/2018/03/05/health/ 
opioid-crisis-judge-lawsuits.html [https://perma.cc/H87X-UYN 
W]. 
4 Transfer Order, In re Nat’l Prescription Opiate Litig., MDL 
No. 1:17-MD-2804 (N.D. Ohio Dec. 12, 2017). 
5 Eric also won the Scripps Howard First Amendment Award, 
was a finalist for the Selden Ring awards, and won a first-place 
award for investigative reporting from the Association for 
Healthcare Journalists. See Susan Heavey, Reporter’s Work 
Pushes Regulators, Legislators to Act on Opioids, ASS’N HEALTH 
CARE JOURNALISTS: COVERING HEALTH (May 8, 2017), 
https://healthjournalism.org/blog/2017/05/reporters-work-
pushes-regulators-legislators-to-act-on-opioids/ [https://perma. 
cc/MDV6-FF6W]. 
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in his articles. Without their tireless efforts, Eric may not 
have been able to prevail against the well-financed 
political and industry resistance to accessing the data 
that so starkly revealed the appalling opiate prescription 
and distribution patterns in West Virginia. 
To put the importance of Eric’s contribution, and 
that of Pat and Suzanne, in perspective, consider the 
odds against which they were fighting - and it is critical 
to remember that, at the time Eric, Pat, and Suzanne 
were seeking the distribution data, the only litigation 
pending against any entity or individual involved in the 
opioid distribution chain was the groundbreaking lawsuit 
filed by then-West Virginia Attorney General Darrell 
McGraw in 2012 against Cardinal Health.6 Eric’s 
newspaper, the Gazette-Mail, was a family-owned, daily 
newspaper with a print circulation of 37,000, and Pat and 
Suzanne were providing their services pro bono.  
Thus, the odds were enormous, considering the 
Goliath-like financial resources of their opposition. 
Opioid painkillers are a nearly $9 billion-a-year market 
in the U.S. alone,7 and pharmaceutical companies such 
as Purdue Pharma L.P., Johnson & Johnson, Teva, 
Allergan PLC, and the Endo Health Solutions unit of 
Endo International PLC have all earned billions over the 
years from the sale of these drugs.8 Wholesale 
distributors like McKesson Corp., Cardinal Health, and 
AmerisourceBergen also have profited,9 as have the 
                                               
6 See Records: Company Shipped Millions of Pills to West 
Virginia, ASSOCIATED PRESS (Oct. 09, 2016), https:// 
www.apnews.com/20ed75eba921466aba2155f4a846dc75 
[https://perm a.cc/P624-LN5W]. 
7 Haley Sweetland Edwards, The Drug Cascade, TIME (June 22, 
2017), http://time.com/4828108/the-drug-cascade/ [https://per 
ma.cc/Q9L5-A84S]. 
8 Stock Review: Two-Bagger Collegium Pharmaceutical Surges 
108%, GLOBAL ROUND UP - STOCKS, Mar. 23, 2018. 
9 Katie Tabeling, County Files Lawsuit Against Opioid 
Manufacturers, CECIL WHIG (Elkton, Md.) (Jan. 9, 2018), 
http://www.cecildaily.com/spotlight/county-files-lawsuit-
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physicians, pain clinics, and pharmacies prescribing and 
dispensing these medications - some legitimately, some 
not.10  
These profits, though, have had a very high public 
health cost, as Eric’s articles helped to expose. Here is 
just a snapshot of the scale of what is being called an 
epidemic11 and what President Trump declared, in 
August of 2017, to be a “national emergency.”12 According 
                                               
against-opioid-manufacturers/article_9be21338-13aa-5855-
b8be-caf98167bf5f.html [https://perma.cc/Y2PV-RXFU] 
(“Among the lawsuit’s 20 manu-facturing defendants, 14 are 
subsidiaries of six pharmaceutical giants, including Endo, 
Purdue, Johnson & Johnson, Teva, Allegran [sic] and 
Mallinckrodt Pharmaceuticals. The remaining defendants are 
McKesson, Cardinal Health and AmerisourceBergen -
characterized in the complaint as ‘the big three’ drug wholesale 
distributors.”); see also Joey Garrison, Nashville Sues Opioid 
Makers, THE TENNESSEAN, Dec. 23, 2017, at A5, 
https://www.tennessean. com/story/news/2017/12/23/nashville-
sues-opioid-manufacturers-recoup-costs-fighting-epidemic/ 
978861001/ [https://perma.cc/3CYT-3L8N] (“Cities like 
Nashville and their taxpayers have borne the cost of the opioid 
epidemic for far too long while the pharmaceutical 
manufacturing industry, consisting of manufacturers and 
distributors, has reaped astronomical profits[.]”). 
10 Chris McGreal, ‘It was a Conspiracy’: Recovering Addicts 
Wage Legal Battle over Prescription Use, GUARDIAN (UK) (Aug. 
28, 2016), https://www.theguardian.com/us-news/2016/aug/ 
28/opioid-addiction-west-virginia-lawsuit [https://perma.cc/Z2 
QP-HCJU] (“29 survivors of opioid addiction or relatives of 
those who overdosed on painkillers . . . accuse doctors, 
pharmacies and distributors in a rural corner of West Virginia 
of pushing the powerful and highly addictive drugs, which have 
properties similar to heroin.”). 
11 U.S. DRUG ENF’T AGENCY, 2015 NATIONAL DRUG THREAT 
ASSESSMENT SUMMARY, at iii (2015), https://www.dea.gov/ 
docs/2015%20NDTA%20Report.pdf [https://perma.cc/5USM-
JQJS]. 
12 Joel Achenbach, John Wagner & Lenny Bernstein, Trump 
Says Opioid Crisis is a National Emergency, Pledges More 
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to the CDC, more than 200,000 people in the U.S. died 
from overdoses related to prescription opioids from 1999 
to 2016.13 In 2016 alone, more than 46 people died every 
day from overdoses involving prescription opioids.14 Also, 
in 2016, three of the six states with the highest rates of 
death due to drug overdose were located in close 
geographic proximity to Tennessee: West Virginia (52.0 
per 100,000), Ohio (39.1 per 100,000), and Kentucky (33.5 
per 100,000).15 Tennessee’s rate was 24.5.16  
These death rates are startling, but perhaps not 
as surprising as one might first imagine given that 
doctors prescribed enough opioids in 2016 to provide 
every man, woman, and child in the U.S. with 36 pills 
each.17 The highest prescribing rates, however, 
reportedly were concentrated in the more rural states 
that year, primarily in the South; in Tennessee, with the 
second highest prescribing rate in the nation, every 
resident could have had 70 pills each in 2016.18  
The West Virginia numbers were even more 
alarming. Eric’s research revealed that, “[i]n six years, 
                                               
Money and Attention, WASH. POST (Aug. 10, 2017), 
https://www.washingtonpost.com/politics/trump-declares-
opioid-crisis-is-a-national-emergency-pledges-more-money-
and-attention/2017/08/10/5aaaae32-7dfe-11e7-83c7-5bd5460f0 
d7e_story.html [https://perma.cc/GTU6-EMRN]. 
13 CTRS. FOR DISEASE CONTROL & PREVENTION, PRESCRIPTION 
OPIOID OVERDOSE DATA, https://www.cdc.gov/drugoverdose/ 
data/overdose.html [https://perma.cc/6HVX-YYKV]. 
14 Id.  
15 CTRS. FOR DISEASE CONTROL & PREVENTION, Rates, DRUG 
OVERDOSE DEATH DATA, https://www.cdc.gov/drugoverdose/ 
data/statedeaths.html [https://perma.cc/Y7SX-YVZK]. 
16 Id. 
17 PACIRA PHARM., INC., UNITED STATES FOR NON-
DEPENDENCE: AN ANALYSIS OF THE IMPACT OF OPIOID 
OVERPRESCRIBING IN AMERICA 11 (2017), https://www. 
pacira.com/sites/default/files/inline-files/USND_Stats_FINAL. 
pdf [https://perma.cc/JAS3-WDWP]. 
18 Id. at Slides 11-12.  
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drug wholesalers showered the state with 780 million 
hydrocodone and oxycodone pills, while 1,728 West 
Virginians fatally overdosed on those two painkillers[.]”19 
Proportionately, in terms of geographical distribution 
and in terms of population, that “amount[s] to 433 pain 
pills for every man, woman and child in West Virginia.”20 
In that state, the data that Eric secured uncovered a 
dismaying pattern of distribution: small, independent 
pharmacies received a disproportionate percentage of the 
shipments of prescription opioids, e.g., wholesale 
distributors delivered 1.4 million to 4.7 million 
hydrocodone pills each year to locally-owned pharmacies 
in Mingo and Logan counties when one of the busiest 
Wal-Mart’s in West Virginia received only about 5,000 
oxycodone and 9,500 hydrocodone pills annually.21 
The companies involved in the opioid distribution 
chain fought tooth-and-nail to keep these data from being 
released, relying upon an impressive array of legal talent 
to defend them on this issue22 and on the other claims of, 
inter alia, negligence, public nuisance, violations of West 
Virginia’s consumer act, etc. that arose in that ground-
                                               
19 Eric Eyre, Drug Firms Poured 780M Painkillers into WV 
amid Rise of Overdoses, W.V. GAZETTE-MAIL (Dec. 16, 2016), 
https://www.wv gazettemail.com/news/cops_and_courts/drug-
firms-poured-m-painkillers-into-wv-amid-rise-of/article_99026 
dad-8ed5-5075-90fa-adb906a36214.html [https://perma.cc/R38 
M-FFSP].  
20 Id. 
21 Id. 
22 AmerisourceBergen Drug Corp.’s Objection to Hearing Date 
and Opposition to Motion on Behalf of the Charleston Gazette 
to Intervene for the Limited Purpose of Moving the Circuit 
Court to Unseal the Plaintiff’s Second Amended Complaint at 
5, State ex rel. Morrissey v. AmerisourceBergen Drug Corp., 
Civil Action No. 12-C-141 (W. Va. Cir. Ct. 2016) (“And if [the 
DEA] protect[s] any of that information from the intrusive 
journalistic nose of the Gazette, then its confidential nature 
must be respected.”).   
6
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breaking case filed against them in West Virginia.23 
Highly regarded national and West Virginia firms such 
as Jones Day; Morgan Lewis; Steptoe & Johnson; 
Jackson Kelly; Bowles Rice; and Spilman Thomas & 
Battle were involved as defense counsel in the West 
Virginia litigation.24   
Pat, Suzanne, and Boone County, West Virginia 
lawyer Tim Conaway provided essential, legal support to 
the Gazette-Mail to force disclosure of the court records 
that revealed these staggering distribution figures.25 The 
sealed complaint in the State’s lawsuit contained 
shipment data supplied by defendants and the U.S. DEA 
during discovery in the case, and the West Virginia 
Attorney General at that time, Patrick Morrisey,26 and 
                                               
23 Complaint, State ex rel. McGraw v. AmerisourceBergen Drug 
Corp., Civil Action No. 12-C-141, 2012 WL 2544646 (W. Va. Cir. 
Ct. 2012).   
24 See, e.g., Docket, West Virginia v. AmerisourceBergen, Civil 
Action No.  2:12-CV-03760 (Closed Mar. 27, 2013). 
25 See supra note 22. A conversation about these events 
between Pat and Eric took place at an event at Washington & 
Lee at https://livestream.com/wlu/wv-opioid/videos/165654080. 
26 It is not without irony that Morrisey, who is running for the 
U.S. Senate as an anti-opioid warrior, see Ken Blackwell, A 
Clear Choice in WV Senate Battle: Conservative Patrick 
Morrisey, TOWNHALL: OPINION (July 14, 2017), 
https://townhall.com/columnists/kenblackwell/ 2017/07/14/a-
clear-choice-in-wv-senate-battle-conservative-patrick-
morrisey-n2354783 [https://perma.cc/9LD5-JD55], lobbied for 
the Healthcare Distribution Management Association, a group 
that represents drug wholesalers, in Washington, D.C. before 
taking office as West Virginia Attorney General in 2013; 
Cardinal Health is a member of this group. Louis Jacobson, A 
Closer Look at Patrick Morrisey’s Family Ties to ‘Big Pharma’, 
POLITIFACT (Mar. 27, 2018), http://www.politifact.com/truth-o-
meter/article/2018/mar/27/closer-look-patrick-morriseys-
family-ties-big-phar/ [https: //perma.cc/S59G-3MBS]. His wife, 
Denise Henry Morrisey, is a partner with a Washington 
lobbying firm retained by a number of major pharmaceutical 
7
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other plaintiffs apparently agreed with the defendants’ 
arguments that the data were proprietary.27 Pat et al. 
filed a motion on behalf of the Gazette-Mail to unseal the 
complaint, and, despite a vigorous and lengthy fight to 
maintain the confidentiality of the records, the judge 
ordered the first ever public release of these previously-
undisclosed data.28  
The import of this legal event cannot be 
overstated - these data shifted the public discourse on the 
opioid crisis. Opioid abuse was of course on the public 
radar, but opinion did not appear to have moved much 
beyond the “blame the addict” and “those damn pill mills” 
mentality. The data in the lawsuit, however, told stories 
of predatory practices and suffering people in pain, and 
they inspired a sense of outrage and urgency that 
prompted enforcement and reform efforts by regulators 
and legislators.29     
In West Virginia alone, for example, Cardinal 
Health and AmerisourceBergen, two of the nation’s “big 
three” drug wholesalers, agreed to pay the State a 
combined $36 million to settle their lawsuits, and at least 
one county commission has filed suit against all of the 
“big three” to recover costs associated with prescription 
drug abuse, with other West Virginia counties and cities 
declaring their intentions to follow suit.30 Beyond West 
                                               
clients, including several involved in the opioid industry, such 
as Allergan, Johnson & Johnson, Janssen, Purdue Pharma, 
and the membership of the Healthcare Leadership Council; 
e.g., Cardinal, Sanofi, Johnson & Johnson, and Pfizer. Id.  
27 Eric Eyre, Drug Firms Fueled ‘Pill Mills’ in Rural WV, W.V. 
GAZETTE-MAIL (May 23, 2016), https://www.wvgazette 
mail.com/news/cops_and_courts/drug-firms-fueled-pill-mills-
in-rural-wv/article_14c8e1a5-19b1-579d-9ed5-770f09589a22. 
html [https://perma.cc/2B SG-3TFD].  
28 See id. 
29 See Heavey, supra note 5. 
30 Eric Eyre, 2 Drug Distributors to Pay $36M to Settle WV 
Painkiller Lawsuits, W.V. GAZETTE-MAIL (Jan. 9, 2017), 
https://www.wvgazettemail.com/news/health/drug-
8
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Virginia’s borders, nearly every state Attorney General 
has either filed a lawsuit against an opioid manufacturer 
or distributor or is involved in an investigation and has 
issued subpoenas for records.31 The MDL litigation 
consolidated in the Northern District of Ohio currently 
involves 400 cases filed by cities, counties, and states 
against manufacturers and distributors of opiates, but 
those involved have publicly acknowledged the 
possibility that individuals, consumers, hospitals, and 
third party payors might be added as plaintiffs.32 The 
                                               
distributors-to-pay-m-to-settle-wv-painkiller-lawsuits/article_ 
b43534bd-b020-5f56-b9f3-f74270a54c07.html [https://perma. 
cc/AVK9-TB9E].  
31 Jerry Mitchell, Judge: Stop the Legal Fights and Curb the 
Opioid Epidemic, CLARION LEDGER (Jan. 26, 2018), 
https://www.clarion ledger.com/story/news/2018/01/26/opioid-
epidemic-litigation-dan-polster/1014046001/ [https://perma.cc/ 
C7J6-82E9]. Tennessee Attorney General Herbert H. Slatery, 
III, for example, filed a 270-page complaint in the Knox County 
Circuit Court in May of 2018 alleging that Purdue Pharma, 
L.P. violated the Tennessee Consumer Protection Act vis-à-vis 
false, deceptive, and/or unsubstantiated claims about its opioid 
products or opioids in general including OxyContin; that it 
breached a 2007 Agreed Final Judgment with the State 
involving the cessation of sales promotions to prescribers 
whose practices showed indications of abuse or diversion; and 
that it created a public nuisance in Tennessee by significantly 
interfering with the commercial marketplace and endangered 
the life and health of the State's residents. See Tennessee’s 
Motion, Memorandum in Support, and Order Granting Leave 
to File Complaint under Seal, State ex rel. Slatery v. Purdue 
Pharma, L.P., No. 1-173-18 (Tenn. Knox Co. Cir. Ct. 2018), 
https://www.tn.gov/content/dam/tn/attorneygeneral/documents/ 
foi/purdue/purdue-motion-5-15-2018.pdf [https://perma.cc/ 
S8E2-QDQC]. 
32 See supra note 4. The Tennessee Attorney General was not, 
at the time of the publication of this Foreword, a party to the 
federal multidistrict litigation pending in Cleveland, Ohio, but 
that Office has publicly stated that it is “voluntarily engaging 
in settlement discussions” in connection therewith. See Press 
9
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lawsuits involve claims as widely divergent as public 
nuisance, negligence, negligent misrepresentation, 
fraud, and unjust enrichment as well as violations of 
consumer protection laws and the state versions of the 
Controlled Substances Act and RICO statute(s).33  
The pool of defendants is also expanding. For 
example, attributing blame and seeking recovery even 
further afield, several cities in West Virginia brought a 
class action suit against the Joint Commission on 
Accreditation of Health Care Organizations on behalf of 
all U.S. cities and towns.34 The Joint Commission is the 
entity that certifies U.S. health care organizations and 
programs. The suit alleges that the Joint Commission’s 
Pain Management Standards “grossly misrepresented 
the addictive qualities of opioids and fostered dangerous 
pain control practices[.]”35  
Outside of the civil context, prosecutors have 
begun to bring charges against individuals for crimes 
involving opioid abuse and distribution. In 2015, the 
Obama-era U.S. Department of Justice issued a memo 
directing federal prosecutors to pursue charges against 
individual defendants.36 As an example of its use of this 
policy, the DOJ charged John Kapoor, former CEO of 
Insys Therapeutics, with conspiracy to commit 
racketeering and mail and wire fraud in connection with 
a bribe and kickback scheme associated with Subsys, the 
                                               
Release No. 18-10, Tenn. Attorney Gen., No. 18-10:  Tennessee 
Attorney General Sues Purdue Pharma (May 15, 2018), 
https://www.tn.gov/attorneygeneral/news/2018/5/15/pr18-
10.html [https://perma.cc/R459-5ZP4].  
33 Id. 
34 Complaint, City of Charleston v. The Joint Commission, No. 
2:17-cv-04267 (S.D.W.V. Nov. 2, 2017).  
35 Id. at 2.  
36 Memorandum from Deputy Att’y Gen. Sally Q. Yates on 
Individual Accountability for Corporate Wrongdoing (Sept. 9, 
2015), https://www.justice.gov/archives/dag/file/769036/download 
[https://perma.cc/8ARN-NPCS].  
10
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company’s powerful synthetic opioid fentanyl in spray 
form.37 Closer to home, in early 2017, a Maryville doctor 
received a 10-year federal prison sentence for serving as 
the supervising and prescribing doctor at a notorious 
Maryville pain clinic.38 
Legislative activity is also taking place in 
response to the momentum generated in the wake of 
Eric’s articles. That activity, however, is focused 
primarily at the state level. As of April 2018, twenty-
eight states had enacted legislation that either limited, 
offered guidance, or listed requirements related to opioid 
prescribing practices.39 Further, every state except 
Missouri has enacted monitoring program legislation 
“designed to reduce doctor shopping and identify patients 
at risk for substance use disorders.”40 In addition to these 
                                               
37 Cynthia McFaddin, Billionaire Charged with Bribing 
Doctors to Prescribe Opioids, NBC NEWS: HEALTH (Oct. 26, 
2017), https://www.nbcnews.com/storyline/americas-heroin-
epidemic/billionaire-charged-bribing-doctors-prescribe-
opioids-n814686 [https://perma.cc/W3D3-L62U] (“The 
corporation is not facing criminal charges and is still selling 
Subsys - some $240 million worth of Subsys just last year.”).  
38 Jamie Satterfield, Doctor for Maryville Pill Mill Draws 10-
year Prison Term, KNOXVILLE NEWS SENTINEL (Feb. 22, 2017), 
https://www.knoxnews.com/story/news/crime/2017/02/22/doctor
-maryville-pill-mill-draws-10-year-prison-term/98268716/ 
[https://perma.cc/437L-KJ5V].  
39 Prescribing Policies: States Confront Opioid Overdose 
Epidemic, NAT’L CONF. ST. LEGISLATURES: STATE ACTION (Apr. 
5, 2018), http://www.ncsl.org/research/health/prescribing-
policies-states-confront-opioid-overdose-epidemic.aspx 
[https://perma.cc/VR62-LA4U].  
40 Chris Elkins, The Opioid Epidemic: What Caused the Heroin 
Epidemic?, DRUGREHAB.COM, https://www.drugrehab.com/ 
opioid-epidemic-causes/ [https://perma.cc/ZX2U-NZ7J]. The 
Prescription Safety Act of 2016 is Tennessee’s version - 
legislation that revised or made permanent existing regulation 
of controlled substances and enacted several other provisions. 
Tennessee Prescription Safety Act of 2016, 2016 Tenn. Pub. 
11
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legislative initiatives, states have considered, proposed, 
and/or adopted opioid-related legislation in a number of 
other categories, including opioid taxes, pain clinic 
licensure, training and education plans, and pill “take-
back” programs.41 
At the federal level, one hears numerous claims 
that actions are being taken to “combat the opioid 
crisis[,]”42 including President Trump’s plan to use the 
death penalty as an option for drug dealers in fatal opioid 
overdose cases.43 Not all have been deemed to be a 
success. For example, an earlier piece of federal 
legislation, the Ensuring Patient Access and Effective 
Drug Enforcement Act of 2016, has been subjected to 
scathing criticism, with even its title described as 
“misleading.”44 According to a report resulting from a 
joint investigation by The Washington Post and “60 
Minutes,” an ex-DEA lawyer working for a 
pharmaceutical company drafted an early version of the 
                                               
Acts 1002 (codified at TENN. CODE ANN. §§ 53-10-301 to -312 
(2016)). 
41 Kate Blackman & Amber Widgery, Summer Progress in 
Opioid Misuse Prevention Legislation, NAT’L CONF. ST. 
LEGISLATURES: NCSL BLOG (Aug. 31, 2017), 
http://www.ncsl.org/blog/2017/08/31/summer-progress-in-
opioid-misuse-prevention-legislation.aspx [https://perma.cc/P 
NT2-ZBM4]. 
42 See, e.g., Combatting the Opioid Crisis, HOUSE COMM. ON 
ENERGY & COM.: ISSUE IN FOCUS, https://energycommerce. 
house.gov/opioids/ [https://perma.cc/V9DA-VNW9].  
43  Louise Radnofsky, Trump’s Opioid Battle Plan Includes 
Seeking More Death-Penalty Prosecutions, WALL ST. J. (Mar. 
18, 2018), https://www.wsj.com/articles/trumps-opioid-battle-
plan-includes-seeking-more-death-penalty-prosecutions-
1521414347 [https://perma.cc/D2JW-N3R6].  
44 Scott Higham & Lenny Bernstein, New Drug Law Makes It 
‘Harder for Us to Do Our Jobs,’ Former DEA Officials Say, 
WASH. POST (Dec. 15, 2017), https://www.washington 
post.com/graphics/2017/investigations/dea-law/?utm_term=.6c 
c2264b1f35 [https://perma.cc/X 8YA-XEXH]. 
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law.45 The final version dramatically curtailed the DEA’s 
enforcement powers: the agency now must demonstrate 
that a company’s actions represent “a substantial 
likelihood of an immediate threat” before it can halt drug 
shipments, whereas previously it needed only to show 
that they posed an “imminent danger” to the 
community.46 The law also allows companies to submit 
“corrective action plans” before they can be sanctioned by 
the DEA,47 which one former DEA investigator called a 
“get out of jail free card[.]”48 
More recently, the new two-year budget deal 
passed in early 2018 promised funding for the epidemic, 
the details of which were not specified.49 Additionally, a 
bipartisan group of senators introduced a follow-up bill to 
2016’s Comprehensive Addiction and Recovery Act, 
commonly referred to as CARA 2.0.50 A version of the bill 
was introduced in the House of Representatives by 
Tennessee Representative Marsha Blackburn.51 If 
passed, CARA 2.0 would, among other things, commit 
more funding to the fight against the opioid crisis, 
restrict access to opioid painkillers, improve access for 
medication-assisted treatment, and increase civil and 
criminal penalties for opioid manufacturers if they fail to 
report suspicious orders or fail to prevent diversion.52 
The impact of Eric’s articles and its aftermath can 
be seen far beyond the nation’s courtrooms and 
                                               
45 Id.  
46 Ensuring Patient Access and Effective Drug Enforcement 
Act of 2016, Pub. L. No. 114-145, § 2(a)(1), 130 Stat. 354 (2016) 
(codified as amended at 21 U.S.C. § 823 (2017)). 
47 Ensuring Patient Access and Effective Drug Enforcement 
Act of 2016, Pub. L. No. 114-145, § 2(a)(2), 130 Stat. 354 
(codified as amended at 21 U.S.C. § 824 (2016)). 
48 See Higham & Bernstein, supra note 44. 
49 See, e.g., Bipartisan Budget Act of 2018, H.R. 1892, 115th 
Cong. § 50723 (2018). 
50 CARA 2.0 Act of 2018, S. 2456, 115th Cong. (2018). 
51 CARA 2.0 Act of 2018, H.R. 5311, 115th Cong. (2018). 
52 Id. 
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legislatures, with some good results and some not as 
positive. Eric discussed some of these results at the 
symposium. For example, while he was relieved that 
many of the opioid “pill mills” in West Virginia had been 
shut down or had voluntarily closed their doors, he 
suspected that a number of them had simply changed the 
signs on their doors and morphed into “treatment 
centers” that use medication to treat the opioid addicts 
that they helped to create.  
Medication-assisted treatment for opioid 
addiction is still very controversial.53 The main criticism 
of using medication in this context is that it is just 
replacing one drug - whether an opioid painkiller or 
heroin - with another, such as methadone, 
buprenorphine, and naltrexone.54 Research clearly 
demonstrates, however, that medication improves 
outcomes for patients with opioid use disorders.55  
Along with the success of these treatments, 
several tag-along legal issues have arisen which are 
worthy of monitoring. One involves claims by the 
Attorneys General of 35 states and the District of 
Columbia that British pharmaceutical manufacturer 
Indivior Inc. and U.S. company MonoSol Rx “product 
hopped” in order to delay less expensive generic versions 
                                               
53 See, e.g., Sameer Hassamal et al., Overcoming Barriers to 
Initiating Medication-Assisted Treatment for Heroin Use 
Disorder in a General Medical Hospital: A Case Report and 
Narrative Literature Review, J. PSYCHOL. PRAC. 221 (2017).  
54 Medication and Counseling Treatment, SUBSTANCE ABUSE & 
MENTAL HEALTH ADMIN. (APR. 8, 2018), https://www. 
samhsa.gov/medication-assisted-treatment/treatment 
[https://perma.cc/5VC4-LULF]. Buprenorphine (Subutex) and 
Buprenorphine-naloxone (Suboxone) were approved by the 
U.S. FDA in 2002 to treat opiate dependence. Naloxone is the 
drug used to revive overdose victims. 
55 Mollie Durkin, Primary Care Takes on Opioid Addiction, 
ACP INTERNIST: OPIOIDS (Oct. 2017), https://acpinternist.org/ 
archives/2017/10/primary-care-takes-on-opioid-addiction.htm 
[https: //perma.cc/L49U-BM2H]. 
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of Suboxone, Indivior’s opioid addiction treatment drug.56 
The defendants in that case are accused of conspiring to 
create a sublingual film version of its Suboxone drug 
shortly before its license expired in order to extend its 
patent; of incrementally increasing the price of its tablets 
and engaging in potentially misleading marketing to 
encourage patients and doctors to switch to the new film 
version; and of then announcing its intent to remove the 
tablets from the market entirely.57 
Another pharmaceutical manufacturer in the 
ever-growing opioid treatment market has drawn fire for 
its marketing practices. Alkermes, a Massachusetts 
company, makes a monthly injectable treatment 
medication called Vivitrol that blocks the effects of 
opioids and reduces cravings, and the company has taken 
its aggressive marketing pitch directly to drug court 
judges, prosecutors, and other officials in the criminal 
justice system who appear receptive to the “nonaddictive” 
qualities of its product.58 According to medical 
professionals, this approach is misleading and 
contributes to the “existing stigma on the use of opioid 
[methadone or buprenorphine] therapy in the treatment 
of opioid addiction, despite a large and robust evidence 
base showing [its] effectiveness . . . for opioid addiction.”59 
In addition to the potentially predatory practices 
of the companies and individuals seeking to exploit the 
market for opioid addiction treatment, there are other 
                                               
56 See Wisconsin v. Indivior Inc., Civ. No. 16-5073, 2017 WL 
3967911 (E.D. Pa. Sept. 8, 2017). 
57 Id. 
58 See, e.g., Press Release, U.S. Senator Kamala Harris, 
Senator Harris Launches Investigation into Pharmaceutical 
Manufacturer Alkermes Regarding Opioid Addiction 
Treatment Manipulation (Nov. 6, 2017), https://www. 
harris.senate.gov/news/press-releases/senator-harris-
launches-investigation-into-pharmaceutical-manufacturer-
alkermes-regarding-opioid-addiction-treatment-manipulation 
[https://perma.cc/G5C7-YFKP]. 
59 Id.  
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obvious downsides to the successful closure of many of 
the unethical pill mills that blighted our rural 
communities. Some of the poor souls who are no longer 
able to access opioid prescriptions have turned to heroin 
or to the very deadly synthetic opioid, fentanyl. According 
to the CDC, “illicitly manufactured fentanyl is now a 
major cause of opioid overdose deaths in multiple 
states.”60 One law enforcement officer compared it to a 
community weapon of mass destruction: “[i]t’s 
manufactured death.”61 
Hopefully, no one will be discouraged from 
seeking to combat the opioid crisis in all of its forms, 
whether the drug has been produced legally or illegally. 
We should look to Eric’s efforts, and those of our 
colleagues whose legal work supported him, for courage 
and inspiration. The unsealed data that Eric and Pat et 
al. secured in West Virginia are still among the only such 
data that are publicly-available. The industry, with 
support from the U.S. Department of Justice and the U.S. 
DEA, is still demanding that its data be protected on the 
grounds that disclosure could violate privacy rights, 
breach trade secrets, interfere with law enforcement 
investigations, and encourage criminal activity.62 This is 
                                               
60 Maggie Fox, Synthetic Fentanyl Deaths Rise in Americans 
Opioid Epidemic, NBC NEWS: HEALTH (Oct. 27, 2017), 
https://www.nbcnews.com/storyline/americas-heroin-epidemic/ 
synthetic-fentanyl-deaths-rise-americans-opioid-epidemic-
n814956 [https://perma.cc/S42J-CTEH].    
61 Nicole Lewis et al., Fentanyl Linked to Thousands of Urban 
Overdose Deaths, WASH. POST: NAT’L (Aug. 17. 2017), 
https://www.washingtonpost.com/graphics/2017/national/fent
anyl-overdoses/?utm_term=.d64447b619c9 [https://perma.cc/ 
ZRV4-N57W].   
62 Letter from David A. Sierleja, First Assistant U.S. Attorney, 
N. Dist. of Ohio, to Paul T. Ferrell, Jr., Partner, Green, 
Ketchum, Farrell, Bailey & Tweel LLP (Feb. 26, 2018), 
https://images.law.com/contrib/content/uploads/documents/39
8/11419/Critical-Mass-opioid-DOJ-letter.pdf [https://perma.cc/ 
EQ9L-FBGV].  
16
Tennessee Journal of Law and Policy, Vol. 13, Iss. 3 [2018], Art. 2
https://trace.tennessee.edu/tjlp/vol13/iss3/2
A ROT IN HEAVEN 
13 TENN. J.L. & POL’Y 267 (2018) 
 
 
[283] 
despite the Justice Department’s request to participate 
in the settlement talks in the large MDL pending in the 
Northern District of Ohio.63  
This reluctance is understandable. The publicly-
available raw numbers in Tennessee are sobering. In 
Knox County alone, there were 294 suspected drug 
overdose deaths in 2017 and 84 so far in 2018. Those are 
not just numbers: those are our children, mothers, 
fathers, siblings, and friends, and each leaves behind 
grieving loved ones, all of whom deserve the best of our 
combined professional efforts. As painful as the truth 
may be, lawyers and journalists should be working to 
uncover it, individually and as partners. Eric and his 
legal support may be a tough, if not an impossible, act to 
follow, but it is one to which I hope that we all will aspire.  
 
 
  
                                               
63 United States’ Motion to Participate in Settlement 
Discussions and as Friend of the Court, In re National 
Prescription Opiate Litigation, MDL No. 1:17-MD-2804 (N.D. 
Ohio April 2, 2018). This apparent cognitive dissonance 
appears to be an issue amongst the manufacturing community, 
too. OxyContin manufacturer Purdue Pharma recently 
announced that it would stop promoting opioids to physicians, 
see OxyContin Maker Purdue Pharma Stops Promoting 
Opioids, Cuts Sales Staff, WASH. POST: HEALTH SCIENCE (Feb. 
10, 2018), https://www.washingtonpost.com/national/health-
science/oxycontin-maker-purdue-pharma-to-stop-promoting-
the-drug-to-doctors/2018/02/10/c59be118-0ea7-11e8-95a5-
c396801049ef_story.html [https://perma.cc/9FR5-4WSP], 
while at the same time “funneling $4.7 million to organizations 
and physicians from 2012 through last year” that promoted the 
use of opioid painkillers. Associated Press, Opioid Makers Gave 
$10 Million to Drug Advocacy Groups Amid Epidemic, NBC 
NEWS: NEWS (Feb. 18, 2018), https://www.nbcnews.com/storyline/ 
americas-heroin-epidemic/opioid-makers-gave-10m-advocacy-
groups-amid-epidemic-n849211 [https://perma.cc/LW39-63UK].  
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